Dr. Arora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
516 Delaware Street SE
UNIV of MN Physicians PWB Fifth floor Clinic 5B
Minneapolis, MN 55455Phone+1 612-273-2800Fax+1 612-625-6919
Summary
- Dr. Mukta Arora is a Hematologist in Minneapolis, MN and is affiliated with University of Minnesota Medical Center, Fairview. She received her medical degree from King George's Medical College and completed a residency in Internal Medicine and Fellowship in Hematology and Oncology from University of Minnesota and has been in practice 17 years. She specializes in and is experienced in stem cell transplantation.
Education & Training
- University of MinnesotaResidency, Internal Medicine, 2001 - 2002
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1997 - 2000
- King George's/CSM Medical CollegeClass of 1993
Certifications & Licensure
- MN State Medical License 2002 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
- Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study Start of enrollment: 2020 Jun 29
Publications & Presentations
PubMed
- 391 citationsComposite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.Shernan G. Holtan, Todd E. DeFor, Aleksandr Lazaryan, Nelli Bejanyan, Mukta Arora
Blood. 2015-02-19 - 130 citationsBelumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar StudyCorey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi
Blood. 2020-11-05 - 879 citationsNational Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Wor...Madan H Jagasia, Hildegard T Greinix, Mukta Arora, Kirsten M Williams, Daniel Wolff
Biology of Blood and Marrow Transplantation. 2015-03-01
Journal Articles
- Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment KineticsErhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica
- A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
- Late Mortality After Allogeneic Blood or Marrow Transplantation in Childhood for Leukemia: A Report from the Blood or Marrow Transplant Survivor Study-2Stephen J Forman, Daniel J Weisdorf, Donna Salzman, Mukta Arora, Saro H Armenian, Nature
Abstracts/Posters
- Stroke Risk in Blood or Marrow Transplant (BMT) Survivors _ a Report from the BMT Survivor Study (BMTSS)Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantatio...Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) - Results of the BMT Survivor Study (BMTSS)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- BMT Survivor Study Finds Significant Breast Cancer Risk in Young Women Who Received Total Body IrradiationJuly 31st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: